MLH1 and Lynch syndrome: Inactive germline mutations in the MMR pathways (including MSH2, MSH6, MLH1, and PMS2) result in deficient MMR, which usually occurs in patients with Lynch syndrome (LS), and somatic promoter hypermethylation of MLH1 in the sporadic cancers (1, 2).